Brain Imaging Devices Market Size & Growth Forecast 2027–2036, By Segments (Product, Modality, End Use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Brain Imaging Devices Market size was over USD 6.6 billion in 2026 and is likely to grow at a 7.79% CAGR between 2027 and 2036, surpassing USD 13.97 billion by 2036. The industry revenue for 2027 is assessed at USD 7.03 billion.
Get more details on this report
Request Free Sample ReportBrain Imaging Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America captured 41.55% of the market in 2026, supported by advanced hospitals, specialized diagnostic networks, strong imaging utilization, and established reimbursement and clinical infrastructure.
- Asia Pacific is projected to grow at a 9.27% CAGR as healthcare infrastructure expands, imaging installations increase, and more facilities adopt advanced diagnostic technologies for neurological care.
Segment Momentum
- Devices held a 77.43% share in 2026 because they form the core imaging platform used across hospitals and diagnostic centers, making them essential for routine clinical brain imaging workflows.
- Portable systems are growing fastest as healthcare providers seek flexible, point-of-care imaging that supports bedside assessments, faster decision-making, and improved access where patient movement is challenging.
Market Expansion Drivers
- Rising neurological disorder prevalence driving demand for advanced diagnostic brain imaging systems.
- AI-enabled portable imaging technologies improving accessibility and diagnostic efficiency.
- Government neurological health initiatives expanding diagnostic infrastructure and awareness programs.
Leading Market Participants
- Leading companies in the brain imaging devices market include GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Medtronic plc (Ireland), Nihon Kohden Corporation (Japan), Compumedics Limited (Australia), MEGIN Oy (Finland), Natus Medical Incorporated (United States), NeuroLogica Corporation (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 6.6 billion
- 2027 Estimated Market Size: USD 7.03 billion.
- Projected Market Size: USD 13.97 billion by 2036
- Growth Forecast: 7.79% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Devices (Product) | Fixed (Modality) | Hospital (End Use) | Brain Tumor (Application)
- Emerging Opportunity Segment: Accessories (Product) | Portable (Modality) | Diagnostic Imaging Centers (End Use) | Epilepsy (Application)
Market Growth Drivers and Industry Trends
Rising neurological disorder prevalence driving demand for advanced diagnostic brain imaging systems
The increasing prevalence of neurological disorders is strengthening the need for diagnostic technologies capable of providing detailed information about brain structure and function. This trend will drive the brain imaging devices market growth as healthcare providers increasingly rely on advanced imaging systems to support the detection, characterization, and monitoring of neurological conditions. Brain imaging can assist clinicians in evaluating abnormalities associated with conditions affecting the brain and nervous system while supporting treatment planning and disease management. The growing clinical emphasis on accurate diagnosis and continuous monitoring is also encouraging healthcare institutions to expand access to sophisticated imaging capabilities.
AI-enabled portable imaging technologies improving accessibility and diagnostic efficiency
Artificial intelligence and advances in portable imaging are creating new opportunities to extend brain diagnostic capabilities beyond conventional hospital-based imaging environments. The brain imaging devices market growth is supported by AI-enabled technologies that can assist with image interpretation, workflow optimization, and identification of clinically relevant patterns, while portable systems can improve access to imaging in decentralized care settings. These capabilities can help reduce operational complexity and support faster assessment where conventional imaging infrastructure may be limited. The combination of intelligent software and compact imaging hardware is also enabling healthcare providers to explore more flexible approaches to neurological assessment and diagnostic workflows.
Government neurological health initiatives expanding diagnostic infrastructure and awareness programs
Government initiatives focused on neurological health are increasing investment in diagnostic infrastructure while improving public awareness of neurological disorders and the importance of timely assessment. Such programs will boost the brain imaging devices market demand by encouraging healthcare systems to strengthen imaging capacity and expand access to diagnostic services. Public health initiatives can also support screening, referral, specialist care, and infrastructure development, creating greater utilization of brain imaging technologies across healthcare networks. Increased awareness among patients and healthcare professionals further supports earlier engagement with diagnostic services when neurological symptoms or risk factors emerge.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising neurological disorder prevalence driving demand for advanced diagnostic brain imaging systems | 2.50% | High | North America, Europe | High | Near Term |
| AI-enabled portable imaging technologies improving accessibility and diagnostic efficiency | 2.20% | Moderate | North America, Asia Pacific | High | Mid Term |
| Government neurological health initiatives expanding diagnostic infrastructure and awareness programs | 1.60% | High | Europe, North America, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The brain imaging devices market was led by North America, which accounted for a 41.55% share in 2026, supported by advanced healthcare infrastructure, strong neurological research capabilities, and broad access to sophisticated diagnostic technologies. Increasing demand for early and accurate detection of neurological disorders is encouraging healthcare providers to adopt advanced imaging systems. Established clinical expertise, continued investment in medical technology, and the integration of high-resolution imaging into neurological diagnosis and treatment planning are further reinforcing the region's leading position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is anticipated to be the fastest-growing region, supported by expanding healthcare infrastructure, increasing awareness of neurological disorders, and improving access to advanced diagnostic technologies. Investments in hospital modernization and specialized medical facilities are creating greater opportunities for sophisticated brain imaging systems. Growing demand for earlier diagnosis and improved neurological care, alongside the development of local healthcare capabilities, is expected to support wider adoption of brain imaging devices across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Imaging PrecisionGermany emphasizes technologically advanced brain imaging devices that support accurate neurological diagnosis and clinical research. Healthcare institutions prioritize equipment with enhanced image quality, workflow optimization, and compatibility with multidisciplinary care environments.
France 🇫🇷
Neuroscience Research SupportFrance combines clinical neuroscience expertise with demand for advanced brain imaging technologies across healthcare and research institutions. Investment priorities include improved imaging performance, data interoperability, and expanded access to precision neurological diagnostics.
Italy 🇮🇹
Hospital Modernization DemandItaly continues upgrading diagnostic imaging infrastructure to strengthen neurological care across healthcare facilities. Demand favors brain imaging devices offering reliable performance, streamlined workflows, and compatibility with evolving hospital digital systems.
Japan 🇯🇵
Aging Care DiagnosticsJapan's brain imaging devices market is supported by growing demand for neurological assessment associated with an aging population. Healthcare providers increasingly adopt imaging technologies that enable earlier diagnosis and improved monitoring of complex neurological conditions.
South Korea 🇰🇷
AI Imaging AdoptionSouth Korea integrates brain imaging devices with digital healthcare initiatives and AI-enabled diagnostic platforms. Hospitals increasingly modernize imaging infrastructure to enhance diagnostic accuracy, operational efficiency, and support for advanced neurological care.
United States 🇺🇸
Advanced Diagnostic IntegrationThe U.S. brain imaging devices market benefits from ongoing adoption of advanced diagnostic technologies across hospitals and neuroscience centers. Healthcare providers increasingly invest in high-resolution imaging systems integrated with AI-assisted analysis to improve neurological assessment and clinical workflow efficiency.
Segment Leadership and Growth Trends
Brain Imaging Devices Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Devices (Largest Segment) vs Accessories (Fastest-Growing Segment)
Devices dominated the brain imaging devices market, accounting for a 77.43% share in 2026, reflecting the central role of imaging systems in diagnosing and monitoring neurological disorders. The segment benefits from continued reliance on advanced imaging modalities for structural and functional assessment of the brain, while improvements in image resolution, scanning efficiency, and diagnostic capabilities support sustained demand for sophisticated imaging equipment across healthcare facilities.
Accessories represent the fastest-growing product segment as imaging centers increasingly require complementary components to improve the usability, accuracy, and operational efficiency of brain imaging systems. Growing utilization of imaging procedures, equipment upgrades, and the need for specialized supporting components are encouraging demand for accessories that enhance patient positioning, image acquisition, workflow management, and overall system performance.
Modality Segment Analysis: Fixed (Largest Segment) vs Portable (Fastest-Growing Segment)
The fixed modality segment held the largest share of the brain imaging devices market in 2026, supported by its established role in hospitals and diagnostic facilities requiring comprehensive and high-performance imaging capabilities. Fixed systems generally provide the infrastructure and advanced functionality needed for detailed neurological examinations, while their integration into dedicated imaging departments supports consistent utilization for complex diagnostic applications.
Portable brain imaging systems are advancing at a faster pace as healthcare providers seek greater flexibility in neurological assessment and access to imaging outside conventional radiology environments. Their mobility can support point-of-care evaluation, bedside diagnostics, emergency care, and use in settings where transporting patients to dedicated imaging rooms may be challenging, strengthening their relevance as healthcare delivery becomes more decentralized.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Devices, Accessories | Devices | Accessories |
| Modality | Fixed, Portable, Wearable | Fixed | Portable |
| End Use | Hospital, Diagnostic Imaging Centers, Ambulatory Surgery Centers, Others | Hospital | Diagnostic Imaging Centers |
| Application | Stroke, Brain Tumor, Traumatic Brain Injury (TBI), Epilepsy, Sleep Apnea, Headache, Structural Anomalies, Others | Brain Tumor | Epilepsy |
Competitive Landscape and Market Positioning
Major players in the brain imaging devices market:
1. GE HealthCare Technologies Inc. (United States)
2. Siemens Healthineers AG (Germany)
3. Koninklijke Philips N.V. (Netherlands)
4. Canon Medical Systems Corporation (Japan)
5. Medtronic plc (Ireland)
6. Nihon Kohden Corporation (Japan)
7. Compumedics Limited (Australia)
8. MEGIN Oy (Finland)
9. Natus Medical Incorporated (United States)
10. NeuroLogica Corporation (United States)
Advancements in diagnostic precision are accelerating transformation in the brain imaging devices market. The brain imaging devices market is increasingly driven by integration of AI-enabled imaging analysis and high-resolution scanning technologies. Innovation is focused on improving diagnostic speed, accuracy, and clinical decision support capabilities.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc. (United States) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| Canon Medical Systems Corporation (Japan) | |||||||
| Medtronic plc (Ireland) | |||||||
| Nihon Kohden Corporation (Japan) | |||||||
| Compumedics Limited (Australia) | |||||||
| MEGIN Oy (Finland) | |||||||
| Natus Medical Incorporated (United States) | |||||||
| NeuroLogica Corporation (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Neurophet | Mar-24 | Neurophet presented AI-driven brain disorder analysis technologies at AD/PD 2024, including tools for predicting amyloid positivity and evaluating neurological conditions. The solutions are approaching commercialization and aim to enhance diagnostic and predictive capabilities in neurodegenerative disease assessment. |
| FUJIFILM India | Mar-24 | FUJIFILM India launched the Echelon Synergy MRI system during its CT & MRI User Conclave. The system enhances imaging performance through faster scan times and improved efficiency, strengthening FUJIFILM’s advanced MRI portfolio for neurological and general diagnostic applications. |
| Philips | Feb-24 | Philips and Synthetic MR launched Smart Quant Neuro 3D, an AI-enabled MRI analytics solution for brain disorders including MS, TBI, and dementia. The system improves tissue quantification and supports clinical decision-making, enhancing diagnostic precision and therapy monitoring in neurology imaging workflows. |
| Canon Medical Systems Ltd. | Nov-23 | Canon Medical Systems launched AI-enhanced CT imaging solutions at RSNA, including Aquilion ONE / INSIGHT Edition and Aquilion Serve SP. The systems are designed to support diagnosis of neurological disorders by improving imaging quality and workflow efficiency in advanced neuroimaging applications. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Brain Imaging Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Purchasing Model | Direct Capital Purchase, Leasing & Equipment Financing, Managed Equipment & Pay-per-Use Models |
| Replacement Cycle | New Facility Installations, Replacement of Existing Systems, Technology Upgrade & Expansion |
| Clinical Workflow | Routine Diagnostic Imaging, Acute & Emergency Imaging, Preoperative & Treatment Planning, Treatment Monitoring & Follow-up |
Brain Imaging Devices Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Neurological Disease Diagnostic Demand Analysis |
|
| Advanced Imaging Adoption Assessment |
|
| AI Integration in Brain Imaging Workflows |
|
Need a different cut of the data?
Request Custom ResearchHow large is the brain imaging devices market?
How will the brain imaging devices industry grow in terms of size and CAGR by 2036?
How is rising neurological disorder prevalence influencing investment priorities in advanced brain imaging systems?
How are AI-enabled portable imaging systems changing deployment strategies in healthcare settings?
Why do Devices account for the largest share of the brain imaging devices market?
Why are Portable systems the fastest-growing modality in the brain imaging devices market?
Why does North America hold the largest share of the brain imaging devices market?
Which region is expected to experience the fastest growth in the brain imaging devices market?
Who holds a significant market share in the brain imaging devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization